PubMed=14449902
Hull R.N., Tritch O.J.
Characterization of cell strains by viral susceptibility.
Natl. Cancer Inst. Monogr. 7:161-172(1962)

Patent=US3904480
Hull R.N., Huseby R.M.
Enhanced production of plasminogen activator.
Patent number US3904480, 09-Sep-1975

PubMed=828141; DOI=10.1007/BF02797469
Hull R.N., Cherry W.R., Weaver G.W.
The origin and characteristics of a pig kidney cell strain, LLC-PK1.
In Vitro 12:670-677(1976)

PubMed=8097873; DOI=10.1023/A:1018954204094
Hori R., Okuda M., Ohishi Y., Yasuhara M., Inui K.-i., Takano M.
Decreased cellular toxicity of neomycin in a clonal cell line isolated from LLC-PK1.
Pharm. Res. 10:573-576(1993)

PubMed=17389150; DOI=10.1016/j.cbpa.2007.02.005
Pine M.D., Greer K.A., Busbee D.L.
Comparison of reactive oxygen scavenging systems between a cetacean (DKN1) and a porcine renal epithelial cell line (LLC-PK1).
Comp. Biochem. Physiol. 147A:550-555(2007)

PubMed=19508353; DOI=10.1111/j.1744-313X.2009.00853.x
Ho C.S., Franzo-Romain M.H., Lee Y.J., Lee J.H., Smith D.M.
Sequence-based characterization of swine leucocyte antigen alleles in commercially available porcine cell lines.
Int. J. Immunogenet. 36:231-234(2009)

PubMed=20555413; DOI=10.1139/y10-023
Gunness P., Aleksa K., Kosuge K., Ito S., Koren G.
Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 cell line in studying drug-induced nephrotoxicity.
Can. J. Physiol. Pharmacol. 88:448-455(2010)

PubMed=33122286; DOI=10.1681/ASN.2020010009; PMCID=PMC7894662
Khundmiri S.J., Chen L.-H., Lederer E.D., Yang C.-R., Knepper M.A.
Transcriptomes of major proximal tubule cell culture models.
J. Am. Soc. Nephrol. 32:86-97(2021)

PubMed=34737324; DOI=10.1038/s41598-021-00779-5; PMCID=PMC8569163
Lung O., Candlish R.C., Nebroski M., Kruckiewicz P., Buchanan C., Moniwa M.
High-throughput sequencing for species authentication and contamination detection of 63 cell lines.
Sci. Rep. 11:21657-21657(2021)